You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
7 October 2025 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, announced on Tuesday that it has completed the acquisition of Verona Pharma plc (Nasdaq:VRNA).Verona is now a wholly owned subsidiary of...
7 October 2025 - Clinical-stage biotechnology company MaaT Pharma (Euronext Paris:MAAT) announced on Tuesday that the independent Data Safety Monitoring Board (DSMB) has completed its second planned safety interim analysis of the Phase 2b PHOEBUS tri...
7 October 2025 - Renew Biotechnologies subsidiary Wasatch BioLabs (WBL), a US sequencing service provider focused on long-read sequencing, announced on Monday the addition of three Oxford Nanopore-developed research-use-only (RUO) assays to its servi...
7 October 2025 - MapLight Therapeutics Inc, a California-based clinical-stage biopharmaceutical company focused on treatment for debilitating central nervous system disorders, said on Monday that it has filed a registration statement on Form S-1 with...
7 October 2025 - US-based biopharmaceutical company Amgen (NASDAQ: AMGN) announced on Monday the launch of AmgenNow, a new direct-to-patient programme starting with Repatha (evolocumab).This follows results from the VESALIUS-CV Phase 3 trial demonstr...
6 October 2025 - Digital health companies DarioHealth Corp (NASDAQ: DRIO) and OneStep announced on Monday a strategic collaboration to integrate smartphone-based, clinical-grade fall risk assessment technology into Dario's multi-condition digita...
6 October 2025 - Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) and British-Swedish biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (Nasdaq:AZN) said on Monday that their therapy DATROWAY (datopotamab deruxtecan) achieved ...